[1] Correia De Sousa M,Gjorgjieva M,Dolicka D,et al.Deciphering miRNAs’ action through miRNA editing[J].Int J Mol Sci,2019,20(24):6249. [2] Lee RC,Feinbaum RL,Ambros V.The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75(5):843-854. [3] Lagos-Quintana M,Rauhut R,Lendeckel W,et al.Identification of novel genes coding for small expressed RNAs[J].Science,2001,294(5543):853-858. [4] Wei Q,Mi Q,Dong Z.The regulation and function of micrornas in kidney diseases[J].IUBMB Life,2013,65(7):602-614. [5] Garg P.A Review of podocyte biology[J].Am J Nephrol,2018,47(Suppl.1):3-13. [6] Nagata M.Podocyte injury and its consequences[J].Kidney Int,2016,89(6):1221-1230. [7] Assady S,Wanner N,Skorecki KL,et al.New insights into podocyte biology in glomerular health and disease[J].J Am Soc Nephrol,2017,28(6):1707-1715. [8] Zhao SM,Zhang T,Qiu Q,et al.MiRNA-337 leads to podocyte injury in mice with diabetic nephropathy[J].Eur Rev Med Pharmacol Sci,2019,23(19):8485-8492. [9] Harvey SJ,Jarad G,Cunningham J,et al.Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease[J].J Am Soc Nephrol, 2008,19(11):2150-2158. [10] Zhdanova O,Srivastava S,Di L,et al.The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy[J].Kidney international,2011,80(7):719-730. [11] Hill N,Michell DL,Ramirez-Solano M,et al.Glomerular endothelial derived vesicles mediate podocyte dysfunction: A potential role for miRNA[J].PLoS One,2020,15(3):e224852. [12] Gebeshuber CA,Kornauth C,Dong L,et al.Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1[J].Nature Med,2013,19(4):481-487. [13] Herman-Edelstein M,Scherzer P,Tobar A,et al.Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy[J].J Lipid Res,2014,55(3):561-572. [14] Christofides A,Papagregoriou G,Dweep H,et al.Evidence for miR-548c-5p regulation of FOXC2 transcription through a distal genomic target site in human podocytes[J].Cell Mol Life Sci,2020,77(12):2441-2459. [15] Su H,Qiao J,Hu J,et al.Podocyte-derived extracellular vesicles mediate renal proximal tubule cells dedifferentiation via microRNA-221 in diabetic nephropathy[J].Mol Cell Endocrinol,2020,518:111034. [16] Rahbar Saadat Y,Hejazian SM,Nariman-Saleh-Fam Z,et al.Glucocorticoid receptors and their upstream epigenetic regulators in adults with steroid-resistant nephrotic syndrome[J].Biofactors,2020,46(6):995-1005. [17] Duan Y,Luo Q,Wang Y,et al.Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy[J].J Bioll Chem,2020,295(37):12868-12884. [18] Wang L,Li H.MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3[J].Biosci Rep,2020,40(4):BSR20193653. [19] Yao T,Zha D,Hu C,et al.Circ_0000285 promotes podocyte injury through sponging miR-654-3p and activating MAPK6 in diabetic nephropathy[J].Gene,2020,747:144661. [20] Li X,Yu HM.Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3[J].Eur Rev Med Pharmacol Sci,2020,24(9):4963-4970. [21] Roy D,Modi A,Khokar M,et al.Microrna 21 emerging role in diabetic complications: A Critical Update[J].Curr Diabetes Rev,2021,17(2):122-135 [22] Li M,Guo Q,Cai H,et al.miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation[J].J Cell Physiol,2020,235(4):3362-3371. [23] Dai Y,Gao M,Li L,et al.MicroRNA-874-3p aggravates doxorubicin-induced renal podocyte injury via targeting methionine sulfoxide reductase B3[J].Oxid Med Cell Longev,2020,2020: 9481841. [24] Liao Y,Wang Z,Wang L,et al.MicroRNA-27a-3p directly targets FosB to regulate cell proliferation,apoptosis,and inflammation responses in immunoglobulin a nephropathy[J].Biochem Biophys Res Commun,2020,529(4):1124-1130. |